지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한약학회 Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 제27권 제7호
- 발행연도
- 2004.1
- 수록면
- 806 - 810 (5page)
이용수
초록· 키워드
오류제보하기
Metformin is a biguanide antihyperglycemic agent often used for the treatment of non-insulin dependent diabetics (NIDDM). In this study, the pharmacokinetics and pharmacodynamics of metformin were investigated in Korean healthy volunteers during a fasting state for over 10 h. In order to evaluate the amount of glucose-lowering effect of metformin, the plasma concentrations of glucose were measured for a period of 10 h followed by the administration of metformin (oral 500 mg) or placebo. In addition, the concentration of metformin in blood samples was determined by HPLC assay for the drug. All volunteers were consumed with 12 g of white sugar 10 minutes after drug intake to maintain initial plasma glucose concentration. The time courses of the plasma concentration of metformin and the glucose-lowering effect were analyzed by nonlinear regression analysis. The estimated $C_{max}$, $T_{max}$, $CL_{t}$/F (apparent clearance), V/F(apparent volume of distribution), and half-life of metformin were 1.42$\{pm}$0.07 $\mu\textrm{g}$/mL, 2.59$\{pm}$0.18h, 66.12$\{pm}$4.6 L/h, 26.63 L, and 1.54 h respectively. Since a significant counterclock-wise hysteresis was found for the metformin concentration in the plasma-effect relationship, indirect response model was used to evaluate pharmacodynamic parameters for metformin. The mean concentration at half-maximum inhibition $IC_{50}$, $k_{in}$, $k_{out}$ were 2.26 $\mu\textrm{g}$/mL, 83.26 $H^{-1}$, and 0.68 $H^{-1}$, respectively. Therefore, the pharmacokinetic-pharmacodynamic model may be useful in the description for the relationship between plasma concentration of metformin and its glucose-lowering effect.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Pharmacokinetics and Pharmacodynamic Consideration of Antimicrobial Use
대한약학회 학술대회
2000 .01
-
Pharmacokinetic and Pharmacodynamic Analysis of CNS Drugs
대한약학회 학술대회
2005 .01
-
Pharmacokinetic and Pharmacodynamic Profiles of BR-A657 in Patients with Essential Hypertension
대한임상약리학회 학술대회
2006 .01
-
The Use of 3-dimensional Cultures for Pharmacokinetic and Pharmacodynamic Study Of Anticancer Agents
대한약학회 학술대회
2004 .01
-
약동학 및 약력학
대한외과학회 학술대회 초록집
2012 .11
-
Pharmacokinetic-Pharmacodynamic Relationships Under Non-controlled Conditions. Disease-Drug Interactions
한국응용약물학회 추계학술발표논문집
2002 .01
-
Collaborative Pharmacokinetic–Pharmacodynamic Research for Optimization of Antimicrobial Therapy
Infection and Chemotherapy
2016 .01
-
Pharmacokinetic-Pharmacodynamic Modeling of Risperidone Effects on Electroencephalography in Healthy Volunteers
대한임상약리학회 학술대회
1994 .01
-
Intergration of Pharmacokinetics and Pharmacodynamics in Early Phase Clinical Evaluations
대한임상약리학회 심포지움
1993 .01
-
Pharmacokinetic and Pharmacodynamic Evaluation of a Novel K+ Channel Activator, SKP-450, in Healthy Volunteers
대한임상약리학회 학술대회
1999 .01
-
항생제 Fluoroquinolones의 약동학 및 약력학에 관한 최신 정보
Urogenital Tract Infection
2015 .01
-
Pharmacokinetics / Pharmacodynamics Integration of Marbofloxacin After a Single Dose Intravenous and Intramuscular Administration in Beagle Dogs
한국실험동물학회 학술발표대회 논문집
2014 .02
-
Antiplatelet Effect of Low Dose Aspirin: Pharmacokinetic/Pharmacodynamic Analysis
대한임상약리학회 학술대회
1996 .01
-
Pharmacokinetic and Pharmacodynamic Characteristics of Ibandronate in Healthy Subjects
대한임상약리학회 학술대회
2006 .01
-
Pharmacokinetic and Pharmacodynamic Interaction between Metformin and (-)-Epigallocatechin-3-gallate
Molecular & cellular toxicology
2009 .01
-
Effect of Ketoconazole on Clopidogrel Pharmacokinetics and Pharmacodynamics in Healthy Subjects
대한임상약리학회 학술대회
2006 .01
-
PK/PD Modeling for Glucose-lowering Effect of Metformin in Korean Volunteers
대한약학회 학술대회
2003 .01
-
Pharmacokinetic and Pharmacodynamic Modeling of Levodopa in Parkinson Disease
대한약학회 학술대회
2002 .01
-
Effect of UGT2B15 Genotype on the Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Lorazepam
대한임상약리학회 학술대회
2004 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0